World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
7238
World Ranking
3766
National Ranking
1724

Marta L. Marthas publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marta L. Marthas sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 102 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marta L. Marthas D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marta L. Marthas sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marta L. Marthas is a researcher affiliated with the University of California, Davis in the United States. Their academic contributions primarily span the fields of Medicine as well as Biochemistry, Genetics and Molecular Biology, with specific focus on Epidemiology and Genetics. The topics addressed in their work include Virology and Viral Diseases, Respiratory Viral Infections Research, and Virus-based Gene Therapy Research.

Their recent published work includes a study titled Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques, released in 2020 and available through UNC Libraries. This paper reflects their engagement in viral disease research, particularly pertaining to vaccine efficacy in simian immunodeficiency virus models.

Martha L. Marthas has frequently collaborated with several coauthors, including Koen K. A. Van Rompay, Zachary D. Abbott, Patricia L. Earl, Linda Buonocore-Buzzelli, and Bernard Moss. These collaborations align with the interdisciplinary nature of their research topics.

Their publications have been concentrated in venues such as UNC Libraries, which serves as a platform for their disseminated research.

  • Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques (2020, UNC Libraries)

  • Koen K. A. Van Rompay
  • Zachary D. Abbott
  • Patricia L. Earl
  • Linda Buonocore-Buzzelli
  • Bernard Moss

  • UNC Libraries

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

  • Epidemiology
  • Genetics

  • Virology and Viral Diseases
  • Respiratory viral infections research
  • Virus-based gene therapy research

Best Publications

  • Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus

    Harry Kestler;Toshiaki Kodama;Douglas Ringler;Marta Marthas

  • Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection.

    Koen K. A. Van Rompay;Christopher J. Berardi;Nancy L. Aguirre;Norbert Bischofberger

  • Passive Immunization of Newborn Rhesus Macaques Prevents Oral Simian Immunodeficiency Virus Infection

    Koen K. A. Van Rompay;Christopher J. Berardi;Stephan Dillard-Telm;Ross P. Tarara

  • Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia.

    Chris J Miller;Marta Marthas;Judith Torten;Nancy J. Alexander

  • Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus.

    Andrew A. Lackner;Peter Vogel;Peter Vogel;Ross A. Ramos;Ross A. Ramos;J. D. Kluge

  • Two Low Doses of Tenofovir Protect Newborn Macaques against Oral Simian Immunodeficiency Virus Infection

    Koen K. A. Van Rompay;Michael B. McChesney;Nancy L. Aguirre;Kimberli A. Schmidt

  • Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus Macaques

    Koen K. A. Van Rompay;Laurie L. Brignolo;Dennis J. Meyer;Christopher Jerome

  • Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV.

    Marta Marthas;S. Sutjipto;J. Higgins;B. Lohman

  • Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.

    Koen K. A. Van Rompay;Lucie Durand-Gasselin;Laurie L. Brignolo;Adrian S. Ray

  • 9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques.

    K. K. A. Van Rompay;J. M. Cherrington;M. L. Marthas;C. J. Berardi

  • A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.

    B. L. Lohman;M. B. McChesney;C. J. Miller;E. McGowan

  • Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.

    Koen K A Van Rompay;Kristina Abel;Jonathan R Lawson;Raman P Singh

  • The Relationship between Simian Immunodeficiency Virus RNA Levels and the mRNA Levels of Alpha/Beta Interferons (IFN-α/β) and IFN-α/β-Inducible Mx in Lymphoid Tissues of Rhesus Macaques during Acute and Chronic Infection

    Kristina Abel;Michelle J. Alegria-Hartman;Kristina Rothaeusler;Marta Marthas

  • Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection.

    K. K.A. Van Rompay;Marta Marthas;R. A. Ramos;C. P. Mandell

  • The Use of Nonhuman Primate Models in HIV Vaccine Development

    Cecilia Morgan;Marta Marthas;Christopher Miller;Ann Duerr

  • Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac).

    Paul A. Luciw;Karen E. S. Shaw;Ronald E. Unger;Vicente Planelles

  • Multispecific Vaccine-Induced Mucosal Cytotoxic T Lymphocytes Reduce Acute-Phase Viral Replication but Fail in Long-Term Control of Simian Immunodeficiency Virus SIVmac239

    Thorsten U Vogel;Matthew R Reynolds;Deborah Heydenburg Fuller;Kathy Vielhuber

  • Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS.

    K. K A Van Rompay;M. G. Otsyula;Marta Marthas;Chris J Miller

  • Titration of an SIVmac251 Stock by Vaginal Inoculation of Indian and Chinese Origin Rhesus Macaques: Transmission Efficiency, Viral Loads, and Antibody Responses

    Marta L. Marthas;Ding Lu;M.C.T. Penedo;Andrew G. Hendrickx

  • Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus.

    Marta L. Marthas;Babak Banapour;Suganto Sutjipto;Mary E. Siegel

Frequent Co-Authors

Koen K. A. Van Rompay
Koen K. A. Van Rompay University of California, Davis
Christopher J. Miller
Christopher J. Miller University of California, Davis
Niels C Pedersen
Niels C Pedersen University of California, Davis
Michael B. McChesney
Michael B. McChesney University of California, Davis
Paul A. Luciw
Paul A. Luciw University of California, Davis
Nancy L. Haigwood
Nancy L. Haigwood Oregon Health & Science University
David C. Montefiori
David C. Montefiori Duke University
Murray B. Gardner
Murray B. Gardner University of California, Davis
Bernard Moss
Bernard Moss National Institutes of Health
Patricia L. Earl
Patricia L. Earl National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in advancing their Immunology knowledge with a healthcare focus, exploring nursing pathways offers promising opportunities. Many affordable options exist, such as cheap psych np programs that combine specialized mental health training with nursing expertise.

Nursing professionals often consider further education to improve their career prospects. Understanding the doctorate in nursing salary across states can help guide decisions when choosing which advanced degree to pursue.

For those who started as Family Nurse Practitioners (FNPs), bridging to more specialized roles is possible through a convenient fnp to acnp bridge program online. This pathway enables nurses to expand into acute care settings efficiently.

Additionally, accelerated options are available for those looking to enter advanced practice nursing quickly. The accelerated np programs allow students with relevant backgrounds to fast-track their education and enter the workforce sooner.

Best Scientists Citing Marta L. Marthas

Recently Published Articles